openPR Logo
Press release

Research Antibodies Market 2020: Soaring Demand Assures Motivated Revenue Share by 2025 | Analysis by BD, Thermo Fisher, Merck, Abcam, Bio-Rad Lab, Roche, Agilent, Danaher, Lonza

04-15-2020 05:05 AM CET | Health & Medicine

Press release from: Business Industry Reports

Research Antibodies Market

Research Antibodies Market

Global Research Antibodies Market Synopsis:

The report covers a forecast and an analysis of the Research Antibodies Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Research Antibodies Market along with the impact they have on the demand over the forecast period.

The Global Research Antibodies Market has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Research Antibodies market size to maintain the average annual growth rate of 6.15% from USD 7800 Million in 2015 to USD 9330 Million in 2019, market analysts believe that in the next few years, Research Antibodies market size will be further expanded, we expect that by 2025, The market size of the Research Antibodies will reach USD 12600 Million.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/240228 .

Major key factors driving the growth of the Global Research Antibodies Market are rapid growth in Proteomics and Genomics research, rising demand for high-quality antibodies for research reproducibility, and the increasing Research & Development activities and expenditure in the life sciences industry. The growing demand for protein therapeutics and personalized medicine, coupled with the development of newly engineered proteins, is expected to open growth avenues for research markets in terms of the uptake of antibodies and reagents.

This report contains a complete product overview and its scope in the market to define the key terms and provide the clients a holistic idea of the market and its tendency. It comprehensively evaluates the Global Research Antibodies Market with different perspectives for the purpose of providing a detailed, informative, and accurate analysis of regional growth, competition, market segmentation, and other important aspects.

Global Key Players:

1 Thermo Fisher Scientific Inc

2 Merck Group

3 Abcam Plc

4 Becton, Dickinson And Company

5 Cell Signaling Technology, Inc.

6 Bio-Rad Laboratories, Inc.

7 F. Hoffmann-La Roche Ltd

8 Agilent Technologies, Inc.

9 Danaher Corporation

10 Lonza

11 Genscript

12 Perkinelmer, Inc.

13 Biolegend, Inc. and More....................

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on "Global Research Antibodies Market Report 2020" @ https://www.businessindustryreports.com/buy-now/240228/single .

Product Type Segmentation

1 Western Blotting

2 Flow Cytometry

3 Enzyme-Linked Immunosorbent Assay (Elisa)

4 Immunohistochemistry

5 Immunofluorescence

Industry Segmentation

1 Proteomics

2 Drug Development

3 Genomics

On the basis of Regional analysis, North America and Europe holds major share in global Research Antibodies market. Moreover, Asia-Pacific is expected to record higher growth rate in Research Antibodies Market during the forecast year.

Big Medical Industry News:

BD (Becton, Dickinson and Company) (April 13, 2020) - BD Announces Second FDA Emergency Use Authorization, CE Mark for New COVID-19 Molecular Diagnostic for Global Use - BD (Becton, Dickinson and Company), a leading global medical technology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for an additional molecular diagnostic test for COVID-19 that can return results in two to three hours. The new test also has been CE marked to the IVD Directive (98/79/EC).

The test, which is run on the BD MAX System, provides additional testing capacity for COVID-19 in the United States and in countries that recognize the CE Mark to test patients and health care workers. The test is in addition to the other tests already available on the BD MAX System from collaborations with BioGX and CerTest and is based on the CDC assay design. The BD MAX System, a molecular diagnostic platform, is already in use at thousands of laboratories worldwide, and each unit is capable of analyzing hundreds of samples over a 24-hour period.

"The new BD COVID-19 test for the BD MAX System will help increase availability of these much-needed tests around the world," said Dave Hickey, president of Integrated Diagnostics for BD. "We continue to work towards a full portfolio of testing options to give health care workers choice and access to the right test for the right situation."

The majority of BD MAX Systems are installed in hospital laboratories, reducing the added time and complexity of needing to send samples to a reference lab. The system is fully automated, reducing the opportunity for human error and increasing the speed to result, and can process 24 samples simultaneously. The assay is based on the same viral RNA targeting sequences and real-time PCR detection method as the test developed by the U.S. Centers for Disease Control and Prevention (CDC).

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/240228 .

Major Points in Table of Contents:

Global Research Antibodies Market Report 2020

1 Research Antibodies Product Definition

2 Global Research Antibodies Market Manufacturer Share and Market Overview

2.1 Global Manufacturer Research Antibodies Shipments

2.2 Global Manufacturer Research Antibodies Business Revenue

2.3 Global Research Antibodies Market Overview

3 Manufacturer Research Antibodies Business Introduction

3.1 Thermo Fisher Scientific Inc. Research Antibodies Business Introduction

3.2 Merck Group Research Antibodies Business Introduction

3.3 Abcam Plc Research Antibodies Business Introduction

3.4 Becton, Dickinson And Company Research Antibodies Business Introduction

3.5 Cell Signaling Technology, Inc. Research Antibodies Business Introduction

About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined - we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune - India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Research Antibodies Market 2020: Soaring Demand Assures Motivated Revenue Share by 2025 | Analysis by BD, Thermo Fisher, Merck, Abcam, Bio-Rad Lab, Roche, Agilent, Danaher, Lonza here

News-ID: 2010786 • Views:

More Releases from Business Industry Reports

Tetracaine Market Exhibits a Lucrative Growth Potential during 2021-2025 | Endo International, Nuvo Pharma, Ferndale Pharma, Galen, Jazz Pharma, Paladin Labs, St Renatus, MSK Pharma
Tetracaine Market Exhibits a Lucrative Growth Potential during 2021-2025 | Endo …
BusinessIndustryReports has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Tetracaine Market” Research Report 2021 provides an in-depth analysis of the Tetracaine with the forecast of market size and growth. The analysis includes addressable market, market by volume, market share by business type and by segment (external and in-house). The research study examines the Tetracaine on the basis of a number of criteria,
Cyber Warfare Market Evenly Poised To Reach A Market Value of US$ By Share, Size and Leading Players (Lockheed Martin, BAE System, Boeing, General Dynamic, Raytheon) | Forecast to 2025
Cyber Warfare Market Evenly Poised To Reach A Market Value of US$ By Share, Size …
Overview of Global Cyber Warfare Market: This report provides in-depth study of “Global Cyber Warfare Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cyber Warfare Market report also provides an in-depth survey of key players in the market organization. According to the market research study, the Cyber Warfare is virtual conflict between state, organization, or country by the use of computer technology to disrupt activities
Covid-19 Impact on Cranio Maxillofacial Implant Market 2021-2025: Business Growth by Top Key Company’s - J&J, Medtronic, B Braun, Boston Medical, Integra, Stryker, Zimmer, CONMED
Covid-19 Impact on Cranio Maxillofacial Implant Market 2021-2025: Business Growt …
Overview of Global Cranio Maxillofacial Implant Market: This report provides in-depth study of “Global Cranio Maxillofacial Implant Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cranio Maxillofacial Implant Market report also provides an in-depth survey of key players in the market organization. According to the market research study, Craniomaxillofacial Implants are medical implants used in surgeries of maxillofacial region such as, head, face, neck, oral,
Beginning of the bloom: The Rise of the Biohacking Market 2021-2025 | Global Key Players - Apple, Fitbit, Synbiota, THE ODIN, HVMN, Thync Global, Moodmetric
Beginning of the bloom: The Rise of the Biohacking Market 2021-2025 | Global Key …
Global Biohacking Market Synopsis: The report covers a forecast and an analysis of the Biohacking Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Biohacking Market along with the impact they have on the demand over the forecast

All 5 Releases


More Releases for Antibodies

Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market? In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market? In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial
Arthritis Monoclonal Antibodies Market Report 2024 - Arthritis Monoclonal Antibo …
"The Business Research Company recently released a comprehensive report on the Global Arthritis Monoclonal Antibodies Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The arthritis monoclonal antibodies
Global Multispecific Antibodies Market Size Antibodies Sales Forecast 2029
Global Multispecific Antibodies Market, Drug Sales, Price & Clinical Trials Insight 2029 Report Highlights: • Global & Regional Market Analysis • Global Multispecific Antibodies Market Opportunity: > USD 40 Billion • Global Multispecific Antibodies Market Sales In 2023: > USD 8 Billion • Number Of Approved Multispecific Antibodies: 14 • Approved Antibodies Global, Regional, Annual & Quarterly Sales Insight • Approved Antibodies Dosage & Pricing Insight • Number Of Multispecific Antibodies: In Clinical Trials: > 900 • Comprehensive Insight On All Antibodies In Clinical Trials By
Global Bispecific Antibody Market Size Bispecific Antibodies Clinical Trials FDA …
Global Bispecific Antibody Market, Drugs Sales, Patent, Price and Clinical Trials Insight 2029 Report Highlights: • Bispecific Antibodies Development Proprietary Platforms Insight: > 30 Platforms • Global Bispecific Antibodies Market Size Yearly and Quarterly Sales (2018 till 2023) • Global Bispecific Antibodies Market Size 2023: > USD 8 Billion • Global Bispecific Antibodies Market Forecast Till 2029 • Approved Bispecific Antibodies Yearly and Quarterly Sales (2018 till 2023) • Approved Bispecific Antibodies Regional Sales (2018 till 2023) • Clinical and Commercial Insight On Approved
Emergence of Tetravalent Antibodies
The emergence of tetravalent antibodies represents a significant advancement in the field of therapeutic antibodies, offering new possibilities for treating complex diseases such as cancer, infectious diseases, and autoimmune disorders. These innovative molecules, capable of binding to four antigens or epitopes simultaneously, provide enhanced specificity, efficacy, and versatility, addressing the limitations of traditional monoclonal and even bispecific antibodies. Download Bispecific, Trispecific and Tetraspecific Antibodies Report: https://www.kuickresearch.com/ccformF.php?t=1721642510 Tetravalent antibodies are designed to engage